Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome. (Q41724174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

lymphoblastic leukemia

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ritsuro Suzuki

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Hiroaki Goto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Takashi Kaneko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yoko Shioda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michiko Kajiwara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kazuo Sakashita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Akira Hayakawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mizuka Miki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Keisuke Kato

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Atsushi Ogawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yoshiko Hashii

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Takeshi Inukai

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chiaki Kato

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hisashi Sakamaki

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hiromasa Yabe

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Koji Kato

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

27 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

148-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

Hematological disorders and leukemia in children with Down syndrome

20 February 2020

cites work

1 reference

How I treat ALL in Down's syndrome: pathobiology and management

21 January 2018

1 reference

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group

21 January 2018

1 reference

Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries

21 January 2018

1 reference

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

21 January 2018

1 reference

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles

21 January 2018

1 reference

Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia

21 January 2018

1 reference

Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.

21 January 2018

1 reference

Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome

21 January 2018

1 reference

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

21 January 2018

1 reference

Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome

21 January 2018

1 reference

Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.

21 January 2018

1 reference

Clinical practice. The care of children with Down syndrome

21 January 2018

1 reference

High incidence of acute lung injury in children with Down syndrome.

21 January 2018

1 reference

New perspectives on the biology of acute GVHD.

21 January 2018

1 reference

Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome.

21 January 2018

1 reference

Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.

21 January 2018

1 reference

Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.

21 January 2018

1 reference

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.25245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25262825%20AND%20SRC:MED&resulttype=core&format=json